AHSG and metabolic dysfunction-associated steatohepatitis: Experimental studies have shown that fetuin-A promotes the expression of proinflammatory cytokines at the mRNA and protein levels [12,30] and chronically responds to inflammatory stimuli [31], leading to the progression from steatohepatitis to NASH [32,33].